This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Efficacy and Safety of Two Fixed-dose Combinations in Men With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia. (BENIPRO) | MicrobiomeTrials
← Back to trials NCT06546735
Efficacy and Safety of Two Fixed-dose Combinations in Men With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia. (BENIPRO) Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-11-30Est. Completion: 2028-04-30
Enrollment target: 816 participantsLocations Eurofarma Laboratorios S.A, São Paulo, São Paulo, Brazil Other microbiome trials you might be interested in Benign Prostatic Hyperplasia Benign Prostatic Obstruction Stress Urinary Incontinence (SUI) Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)
Bipolar enucleation of the prostate is an effective operation for men with urinary obstruction caused by a benign enlarg…
Multiple Locations Est. completion May 30, 2028
Benign Prostatic Hyperplasia Benign Prostatic Obstruction Stress Urinary Incontinence Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)
Holmium laser enucleation of the prostate (HoLEP) is an effective operation for men with urinary obstruction caused by a…
Multiple Locations Est. completion May 30, 2028